New York State Common Retirement Fund Rhythm Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 16,850 shares of RYTM stock, worth $896,757. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,850
Previous 16,850
-0.0%
Holding current value
$896,757
Previous $883,000
6.8%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding RYTM
# of Institutions
216Shares Held
64.4MCall Options Held
445KPut Options Held
26.6K-
Black Rock Inc. New York, NY6.74MShares$359 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA6.57MShares$350 Million0.29% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$324 Million5.51% of portfolio
-
Baker Bros. Advisors LP New York, NY6.08MShares$324 Million3.77% of portfolio
-
Perceptive Advisors LLC New York, NY3.68MShares$196 Million6.86% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $2.97B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...